You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Advanced Glycosylation End Product-Specific Receptor (AGER) Antibodies

Full name:
anti-Advanced Glycosylation End Product-Specific Receptor Antibodies (AGER)
On www.antibodies-online.com are 284 Advanced Glycosylation End Product-Specific Receptor (AGER) Antibodies from 30 different suppliers available. Additionally we are shipping Advanced Glycosylation End Product-Specific Receptor Kits (80) and Advanced Glycosylation End Product-Specific Receptor Proteins (37) and many more products for this protein. A total of 419 Advanced Glycosylation End Product-Specific Receptor products are currently listed.
Synonyms:
AGER, RAGE
list all antibodies Gene Name GeneID UniProt
AGER 177 Q15109
AGER 11596  
AGER 81722  

Show all species

Show all synonyms

Most Popular Reactivities for anti-Advanced Glycosylation End Product-Specific Receptor (AGER) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Advanced Glycosylation End Product-Specific Receptor Antibodies

Go to our pre-filtered search.

Top referenced anti-Advanced Glycosylation End Product-Specific Receptor Antibodies

  1. Human Polyclonal AGER Primary Antibody for IHC (p), WB - ABIN389027 : Schlueter, Hauke, Flohr, Rogalla, Bullerdiek: Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? in Biochimica et biophysica acta 2003 (PubMed)
    Show all 4 references for ABIN389027

  2. Human Polyclonal AGER Primary Antibody for IF, IHC (p) - ABIN1108826 : Bierhaus, Haslbeck, Humpert, Liliensiek, Dehmer, Morcos, Sayed, Andrassy, Schiekofer, Schneider, Schulz, Heuss, Neundörfer, Dierl, Huber, Tritschler, Schmidt, Schwaninger, Haering, Schleicher, Kasper et al.: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. ... in The Journal of clinical investigation 2004 (PubMed)
    Show all 4 references for ABIN1108826

  3. Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN357685 : Shanmugam, Kim, Lanting, Natarajan: Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. in The Journal of biological chemistry 2003 (PubMed)
    Show all 3 references for ABIN357685

  4. Cow (Bovine) Polyclonal AGER Primary Antibody for WB - ABIN2786877 : Luo, Saiardi, Nagata, Ye, Yu, Jung, Luo, Jain, Sawa, Snyder: GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase. in Neuron 2001 (PubMed)
    Show all 2 references for ABIN2786877

  5. Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN359696 : Miyata, Akashi, Nishida: Molecular cloning and characterization of a novel member of the MAP kinase superfamily. in Genes to cells : devoted to molecular & cellular mechanisms 1999 (PubMed)
    Show all 2 references for ABIN359696

  6. Human Polyclonal AGER Primary Antibody for FACS, IHC (p) - ABIN651054 : Rojas, Figueroa, Morales: Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. in Carcinogenesis 2010 (PubMed)

  7. Cow (Bovine) Polyclonal AGER Primary Antibody for WB - ABIN2776831 : Galichet, Weibel, Heizmann: Calcium-regulated intramembrane proteolysis of the RAGE receptor. in Biochemical and biophysical research communications 2008 (PubMed)

  8. Human Polyclonal AGER Primary Antibody for EIA, WB - ABIN453330 : Peng, Lu, Wang, Yan, Chen, Zhang, Zhang, Shen: RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. in Archives of medical research 2009 (PubMed)

  9. Human Polyclonal AGER Primary Antibody for IHC, WB - ABIN2776917 : Lieuw-a-Fa, Schalkwijk, Engelse, van Hinsbergh: Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. in Thrombosis and haemostasis 2006 (PubMed)

More Antibodies against Advanced Glycosylation End Product-Specific Receptor Interaction Partners

Human Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. Our data shows that subjects with pre-diabetes exhibited low endogenous secreatory RAGE plasma levels and gene expression, which are inversely related with markers of inflammation and atherosclerotic risk.

  2. S100A5 (show S100A5 Antibodies) employs the periphery of the dimer interface to interact with RAGE-v

  3. Blocking the interaction between S100A9 (show S100A9 Antibodies) and RAGE V domain is a novel route to drug development against cell proliferation.

  4. The T allele of rs2070600, which codes for the RAGE-Ser82 variant, was found to be associated with increased lung function in a cohort of UK smokers and the levels of sRAGE were found to be lower in the serumof smoking individuals carrying this variant.

  5. The authors propose that HMGB1 (show HMGB1 Antibodies) dimers may preferentially bind DNA, whereas HMGB1 (show HMGB1 Antibodies) tetramers may promote inflammatory responses by binding to RAGE and Toll (show TLR4 Antibodies)-like receptors.

  6. serum esRAGE levels are regulated by a newly identified specific haplotype in AGER and a subpopulation of schizophrenic patients are more vulnerable to carbonyl stress

  7. Platelet-derived HMGB1 (show HMGB1 Antibodies) mediated monocyte migration via the receptor for advanced glycation end products (RAGE) and suppressed apoptosis via toll-like receptor 4 (TLR4 (show TLR4 Antibodies))-dependent activation of MAPK/ERK (show MAPK1 Antibodies) (extracellular signal-regulated kinase) in monocytes. In conclusion, we identify platelet-derived HMGB1 (show HMGB1 Antibodies) as a critical regulator of monocyte recruitment and apoptosis, with potential implications in disease states associated

  8. Our data indicate that the RAGE -429T/C polymorphism of the RAGE may be associated with the susceptibility of schizophrenia.

  9. The initial study on the correlation between RAGE gene and PCOS indicates that the two polymorphisms of RAGE are not associated with the pathogenesis of PCOS.

  10. The 2184A/G polymorphism in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes mellitus.

Cow (Bovine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. Our results suggested that the increased RAGE expression in inflammatory circumstances and interaction with AGEs are risk factors in decreasing of aggrecan (show ACAN Antibodies) content in nucleus pulposus.

Mouse (Murine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. These findings demonstrate the role for RAGE-dependent IL-10 (show IL10 Antibodies) suppression as a key modulator of mortality from Gram-negative sepsis.

  2. HMGB1 (show HMGB1 Antibodies) promotes intraoral palatal wound healing through RAGE-dependent mechanisms.

  3. These findings suggest that the inhibitory effect of these plant extracts on the activation of AGEs/RAGE/SphK1 (show SPHK1 Antibodies) signaling pathway in db/db (show LEPR Antibodies) diabetic mice kidney is a novel mechanism by which they exert renoprotective effects in diabetic nephropathy.

  4. Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 (show DIAPH1 Antibodies) Signal Transduction.

  5. Interaction of extracellular S100A4 (show S100A4 Antibodies) with RAGE prompts prometastatic activation of melanoma cells.

  6. Study demonstrated that 1,25(OH)2D3, the active form of vitamin D, plays an important role in increasing Abeta1-40 vectorial transport from the brain to blood and systemic clearance from peripheral circulation through increasing LRP1 (show LRP1 Antibodies) levels both in vivo and in vitro, and reducing RAGE level in the blood-brain barrier model in vitro

  7. This present study confirmed an important role of RAGE in vivo and vitro models of pulmonary fibrosis and suggested the therapeutic possibility for pulmonary fibrosis via RAGE regulation

  8. beta-Caryophyllene protects against GalN (show GAL Antibodies)/LPS (show TLR4 Antibodies)-induced liver injury through down-regulation of the TLR4 (show TLR4 Antibodies) and RAGE signaling.

  9. AGER and its functions to stimulate O-GlcNAcylation are important during liver tumorigenesis, when high blood glucose levels are inadequately controlled.

  10. HMGB1 (show HMGB1 Antibodies) and its main receptor, RAGE, appear to be crucial factors in the pathogenesis of TnI (show TNNI2 Antibodies)-induced experimental autoimmune myocarditis.

Advanced Glycosylation End Product-Specific Receptor (AGER) Antigen Profile

Antigen Summary

The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847).

Alternative names and synonyms associated with Advanced Glycosylation End Product-Specific Receptor (AGER)

  • advanced glycosylation end product-specific receptor (AGER) antibody
  • advanced glycosylation end product-specific receptor (Ager) antibody
  • advanced glycosylation end product-specific receptor (LOC100343142) antibody
  • AGER antibody
  • RAGE antibody

Protein level used designations for AGER

advanced glycosylation end product-specific receptor , RAGE isoform NtRAGE-delta , RAGE isoform sRAGE-delta , RAGE/AGER , advanced glycation end product receptor , advanced glycosylation end product-specific receptor variant 1 , advanced glycosylation end product-specific receptor variant 3 , advanced glycosylation end product-specific receptor variant 4 , advanced glycosylation end product-specific receptor variant 5 , advanced glycosylation end product-specific receptor variant 6 , advanced glycosylation end product-specific receptor variant 7 , advanced glycosylation end product-specific receptor variant 8 , receptor for advanced glycosylation end products , advanced glycation end-products receptor , advanced glycosylation end product-specific receptor variant 2

GENE ID SPECIES
462584 Pan troglodytes
177 Homo sapiens
403168 Canis lupus familiaris
396591 Sus scrofa
280986 Bos taurus
11596 Mus musculus
81722 Rattus norvegicus
100343142 Oryctolagus cuniculus
100726130 Cavia porcellus
101111586 Ovis aries
Selected quality suppliers for anti-Advanced Glycosylation End Product-Specific Receptor (AGER) Antibodies
Did you look for something else?